ICUINasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

ICU MEDICAL INC/DE

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$161.24−1.75 (-1.07%)

Close on Oct 19, 2026

Market cap: $4.04B
P/E (TTM): 134.4
Dividend yield: –

Dividends

Icu Medical has not reported a dividend

No dividend per share appears in Icu Medical's annual filings since fiscal 2010.

Where these numbers come from

Parsed from the XBRL in Icu Medical's annual and quarterly filings with the SEC
Per-share figures adjusted for the 3-for-2 split on Mar 18, 2002
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ICUI.

Revenue growth-9.0% · median 14.3%

Gross margin39.1% · median 54.2%

Operating margin3.3% · median 4.0%

Net margin1.4% · median -0.4%

Company	Revenue	Growth
MMED	$3.10B	+14.3%
TFX	$2.25B	+30.7%
ICUI	$2.16B	-9.0%
IART	$1.65B	+1.6%
MMSI	$1.58B	+10.2%
PEN	$1.50B	+17.6%

Company

Next earnings (est.): Nov 5, 2026, during market hours
Exchange: Nasdaq
Industry: Surgical & Medical Instruments & Apparatus
Fiscal year ends: December 31
Employees: 13,000
Held by institutions: 100.0%
Auditor: DELOITTE & TOUCHE LLP
SEC CIK: 883984

Advertisement
300 × 250